UPS Remains Too Cheap To Ignore

United Parcel Service (UPS) reported mixed Q1 results, with revenue down 0.7% to $21.546 billion but adjusted EPS up 4.2% to $1.49, both exceeding estimates due to improved operating margin. While the U.S. domestic segment showed strength, international profit declined, and the company projects a weaker Q2 with intensifying revenue declines of 3.67% and a 20 basis point operating margin contraction, citing demand and trade uncertainty. Despite this challenging outlook and the stock's underperformance relative to the S&P 500, its P/S ratio is at multi-year lows, leading the author to reiterate a buy rating, arguing market pessimism is excessive given the 6.61% dividend yield and historical performance context.

Analysis

United Parcel Service (UPS) reported a mixed first quarter, characterized by operational efficiency gains set against declining top-line revenue and volumes. While Q1 revenue fell 0.7% year-over-year to $21.546 billion, this figure surpassed consensus estimates by a notable $496.76 million, indicating that market expectations were low. The company's profitability improved, with adjusted EPS rising 4.2% to $1.49, driven by a 20 basis point expansion in adjusted operating margin to 8.2%. Segment performance was divergent: the U.S. Domestic segment saw a 19.4% increase in adjusted operating profit despite a 3.5% decline in average daily volume, whereas the International segment's operating profit fell 4.1% on margin contraction, attributed to a shift toward lower-margin services in Europe. The forward-looking outlook presents a significant headwind, with management guiding for an accelerated Q2 revenue decline of approximately 3.67% and a 20 basis point contraction in company-wide operating margin, citing trade uncertainty and lower demand-related surcharges. Despite these weak fundamentals, the stock's price-to-sales ratio has contracted to a multi-year low of 0.933, and the company offers a substantial 6.61% dividend yield, forming the basis of a value-oriented investment thesis.

Key Decisions for Investors

• Investors should weigh the stock's compelling valuation, indicated by a multi-year low P/S ratio and a 6.61% dividend yield, against the negative forward guidance which forecasts accelerating revenue declines and margin pressure in Q2.
• Monitor international operating margins and U.S. domestic average daily volume closely in the next earnings report, as these metrics are key indicators of the impact from trade uncertainty and demand shifts.
• For long-term investors, the strategic initiatives, including the Andlauer Healthcare acquisition and the AI-powered 'Global Checkout' platform, represent potential future growth catalysts that could offset the current cyclical weakness.
• Given the weak Q2 outlook and receding near-term technical momentum, investors should be prepared for continued stock price volatility and potential underperformance relative to the broader market in the short term.